DES and bioadaptator technologies in contemporary practice

Facilitators: P. Juni, M. C. Morice

Summary

Delve into contemporary practice with this session on drug-eluting stents (DES) and bioadaptator technologies. Gain insights from international studies on complex PCI outcomes, comparative data from randomized trials, and real-world experiences focusing on high bleeding risk patients and elderly cohorts treated with ultrathin strut and new-generation DES.

Presentations available when logged in:

  • Real-world outcomes of complex PCI: insights from a multicentre international study of 2001 patients
  • PCI of complex lesions with bioadaptor or zotarolimus DES: insights from the BIODAPTOR-RCT
  • Ultrathin strut DES in left main stem PCI: observational real-world data
  • New-generation DES in high-bleeding-risk patients with ACS: insights from the BIOFLOW-DAPT RCT
  • Elderly patients treated with two DES in a sub-study of the randomised BIONYX trial